Position in LYEL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,527
New position
Shares Held
126
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Seneschal Advisors, LLC holds $5,173 across 7 Biotechnology names. LYEL ranks #1 (48.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LYEL |
Lyell Immunopharma, Inc.
This page
|
126 | $2,527 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2 | $893 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1 | $772 | |
| 4 | INCY |
Incyte Corp
|
5 | $470 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1 | $330 | |
| 6 | INSM |
INSMED Inc
|
1 | $163 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
1 | $18 |
All Filings in LYEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,527 | 126 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||